COX-2 and its downstream effector prostaglandin E2 (PGE2), a major mediator of inflammation and angiogenesis, are involved in shaping the tumor microenvironment through the modulation of inflammatory mediators, thereby promoting tumor growth and immune escape (Bell et al., 2022). This evidence concerns the gene PTGS2 and neoplasm.